This protocol is judged by an institutional evaluation board, an unbiased group that opinions any medical trials involving human beings. If a research consists of a Routine I drug, after the board approves the protocol as ethical, the scientists must submit an application for an investigational new drug (IND) number through the FDA.And Considering